Amarin Corporation plc - American Depositary Shares (AMRN)
0.5288
0.00 (0.00%)
Amarin Corporation is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products to improve cardiovascular health
The company’s flagship product targets specific cardiovascular conditions and aims to provide effective solutions supported by rigorous clinical research. Amarin is dedicated to advancing the science of lipid management, enhancing treatment options for patients, and addressing key unmet medical needs in the cardiovascular space. Through its commitment to research and development, Amarin seeks to expand its product offerings and improve health outcomes for individuals at risk of cardiovascular diseases.

AMRN earnings call for the period ending September 30, 2024.
Via The Motley Fool · October 31, 2024

AMRN earnings call for the period ending June 30, 2024.
Via The Motley Fool · July 31, 2024

Discover the top breakthrough stocks under $10 with strong fundamentals and strategic advantages to hit massive upside.
Via InvestorPlace · July 29, 2024

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via Investor's Business Daily · July 5, 2024

Companies Reporting Before The Bell • Frontline (NYSEFRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via Benzinga · February 29, 2024

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.
Via The Motley Fool · January 10, 2024

Amarin Corp PLC (NASDAQAMRN) shares are trading by around 28% after the company reported
Via Benzinga · January 10, 2024

Via Benzinga · June 4, 2024

AMRN earnings call for the period ending March 31, 2024.
Via The Motley Fool · May 1, 2024

AMRN stock results show that Amarin Corp beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

Via Benzinga · April 24, 2024

There was unambigously good news about the company's single commercialized medication.
Via The Motley Fool · April 3, 2024

AMRN earnings call for the period ending December 31, 2023.
Via The Motley Fool · February 29, 2024

Amarin's Q4 2023 financials: Revenues at $74.71 million, beating consensus. US net product revenue is $64.9 million, down Y/Y. CEO Patrick Holt shares operational progress, including European market signs. Amarin initiates a $50 million buyback, on track for $40 million in annual savings.
Via Benzinga · February 29, 2024

Shares of TechTarget, Inc. (NASDAQTTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged 14.4% to $40.34 on Thursday.
Via Benzinga · January 11, 2024

Shares of Butterfly Network, Inc. (NASDAQBFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via Benzinga · February 29, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSEASPN) fell sharply during Thursday’s session after the company issued a business update.
Via Benzinga · January 11, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The S&P 500 also rose, gaining, 0.48% to 4,779.31.
Via Benzinga · January 10, 2024

Shares of WD-40 Company (NASDAQWDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via Benzinga · January 10, 2024

Via Benzinga · January 10, 2024

Amarin Corporation (NASDAQAMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional s
Via Benzinga · January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P 500 also rose, gaining, 0.21% to 4,766.64.
Via Benzinga · January 10, 2024

Via Benzinga · January 10, 2024

Via Benzinga · December 4, 2023